We demonstrated that CDK7 activity is necessary for STAT-dependent transcription, an approach that could benefit patients with tumours that present interleukin- or mutation-driven activation of STAT programs like in PTCL22, 23, 28, 41 or other malignances42, 43. Here, CDK7 is linked to neoplasm.